Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$39.76 USD
+0.94 (2.42%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $39.82 +0.06 (0.15%) 6:32 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-2.12 | -13.61% |
Earnings Summary
For their last quarter, Rhythm Pharmaceuticals (RYTM) reported earnings of -$0.70 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for RYTM's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$2.12 per share, reflecting a year-over-year decrease of 130.43%.
Earnings History
Price & Consensus
Zacks News for RYTM
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
RYTM: What are Zacks experts saying now?
Zacks Private Portfolio Services